<DOC>
	<DOCNO>NCT01241162</DOCNO>
	<brief_summary>This treatment study relapse high-risk neuroblastoma , Ewings sarcoma , osteogenic sarcoma , rhabdomyosarcoma synovial sarcoma involve autologous cancer testis ( CT ) antigen specific dendritic cell ( DC ) vaccine precede decitabine demethylating chemotherapy .</brief_summary>
	<brief_title>Decitabine Followed Cancer Antigen Vaccine Patients With Neuroblastoma Sarcoma</brief_title>
	<detailed_description>For vaccine production , mature DC pulse overlap peptide mix derive full-length NY-ESO-1 , MAGE-A1 , MAGE-A3 .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Rhabdomyosarcoma</mesh_term>
	<mesh_term>Sarcoma , Synovial</mesh_term>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Poly ICLC</mesh_term>
	<mesh_term>Decitabine</mesh_term>
	<mesh_term>Azacitidine</mesh_term>
	<criteria>Confirmed diagnosis relapse highrisk neuroblastoma , Ewings sarcoma , osteogenic sarcoma , rhabdomyosarcoma , synovial sarcoma Patient may gross tumor treat multiagent chemotherapy prior study entry , need gross tumor prior study entry . Patients must diagnosis neuroblastoma sarcoma either histological verification neuroblastoma and/or demonstration tumor cell bone marrow increase urinary catecholamine . Have receive standard chemotherapy and/or SCT , least 6 month posttransplant . Age : Patients must 1 &lt; 25 year age register study . Organ Function Requirements : All patient must adequate organ function define : Hematological Function : ANC ≥ 500 ; Platelet count ≥ 75 . Renal Function : Creatinine clearance radioisotope GFR ≥ 70ml/min/1.73 m2 OR A maximum serum creatinine ( mg/dL ) base age/gender follow : 1YO M &amp; F = 0.6 , 25YO M &amp; F = 0.8 , 69YO M &amp; F = 1 , 1012YO M &amp; F = 1.2 , 1315YO M = 1.5 , 1315YO F = 1.4 , 16+ M = 1.7 , 16+ F = 1.4 Cardiac Function : Patient must normal cardiac function document Ejection fraction ( &gt; 55 % ) document echocardiogram radionuclide MUGA evaluation OR Fractional shortening ( ≥ 28 % ) document echocardiogram Liver Function : Total bilirubin ≤ 1.5 x normal age , AND SGPT ( ALT ) SGOT ( AST ) ≤ 3 x normal age . Room air pulse oximetry &gt; 94 % . Male female sexually active patient reproductive age wish participate must agree use acceptable contraception . Lansky performance scale &gt; 70 , ECOG &lt; 2 ( Appendix I ) . Patient pregnant . Patients positive result follow diagnostic test : Hep B Ag , Hep B Core Ab , Hep C Ab , HIV1 Ab , HIV2 Ab , HTLV1 Ab , HTLV2 Ab , RPR . Patient history autoimmune disease , specifically inflammatory bowel disease , systemic lupus erythematosis , rheumatoid arthritis . Patient receive concurrent systemic steroid therapy . Patient known systemic hypersensitivity DAC , Hiltonol , vaccine component .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Neuroblastoma</keyword>
	<keyword>Ewings sarcoma</keyword>
	<keyword>osteogenic sarcoma</keyword>
	<keyword>rhabdomyosarcoma</keyword>
	<keyword>synovial sarcoma</keyword>
	<keyword>high-risk</keyword>
	<keyword>relapse</keyword>
	<keyword>child</keyword>
</DOC>